|
|
|
Item Details
Title:
|
ANTICANCER DRUG DEVELOPMENT GUIDE
PRECLINICAL SCREENING, CLINICAL TRIALS, AND APPROVAL |
By: |
Beverly A. Teicher (Editor), Paul Andrews (Editor) |
Format: |
Hardback |
List price:
|
£199.99 |
We currently do not stock this item, please contact the publisher directly for
further information.
|
|
|
|
|
ISBN 10: |
1588292282 |
ISBN 13: |
9781588292285 |
Publisher: |
HUMANA PRESS INC. |
Pub. date: |
1 February, 2004 |
Edition: |
2nd Revised edition |
Series: |
Cancer Drug Discovery and Development |
Pages: |
451 |
Description: |
Provides a step-by-step guide to anticancer drug development from initial design through FDA approval. The authors have included material on the use of high throughput screening in industry, and on specialized in vitro/in vivo procedures employed by the National Cancer Institute (NCI) in preclinical drug evaluations. |
Synopsis: |
This unique volume traces the critically important pathway by which a "molecule" becomes an "anticancer agent. " The recognition following World War I that the administration of toxic chemicals such as nitrogen mustards in a controlled manner could shrink malignant tumor masses for relatively substantial periods of time gave great impetus to the search for molecules that would be lethal to specific cancer cells. Weare still actively engaged in that search today. The question is how to discover these "anticancer" molecules. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Second Edition describes the evolution to the present of preclinical screening methods. The National Cancer Institute's high-throughput, in vitro disease-specific screen with 60 or more human tumor cell lines is used to search for molecules with novel mechanisms of action or activity against specific phenotypes. The Human Tumor Colony-Forming Assay (HTCA) uses fresh tumor biopsies as sources of cells that more nearly resemble the human disease. There is no doubt that the greatest successes of traditional chemotherapy have been in the leukemias and lymphomas.Since the earliest widely used in vivo drug screening models were the murine L 1210 and P388 leukemias, the community came to assume that these murine tumor models were appropriate to the discovery of "antileukemia" agents, but that other tumor models would be needed to discover drugs active against solid tumors. |
Illustrations: |
161 black & white illustrations, biography |
Publication: |
US |
Imprint: |
Humana Press Inc. |
Returns: |
Returnable |
|
|
|
|
Ramadan and Eid al-Fitr
A celebratory, inclusive and educational exploration of Ramadan and Eid al-Fitr for both children that celebrate and children who want to understand and appreciate their peers who do.
|
|
|
|
|
|
|
|
|
|
|